Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes.
暂无分享,去创建一个
[1] S. Haffner,et al. Effects of Diabetes and Level of Glycemia on All-Cause and Cardiovascular Mortality: The San Antonio Heart Study , 1998, Diabetes Care.
[2] E. Barrett-Connor,et al. Chapter 19 Heart Disease and Diabetes , 2022 .
[3] Terje R Pedersen,et al. Cholesterol Lowering With Simvastatin Improves Prognosis of Diabetic Patients With Coronary Heart Disease: A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S) , 1997, Diabetes Care.
[4] H. King,et al. Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections , 1998, Diabetes Care.
[5] R. Holman,et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study , 2000, BMJ : British Medical Journal.
[6] W. Newton,et al. Tight blood pressure control in type 2 diabetes. , 1998, The Journal of family practice.
[7] The National Diabetes Education Program: Changing the Way Diabetes Is Treated , 1999, Annals of Internal Medicine.
[8] K. Flegal,et al. Racial and ethnic differences in glycemic control of adults with type 2 diabetes. , 1999, Diabetes care.
[9] Daniel W. Jones,et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.
[10] S. Genuth,et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.
[11] R. Holman,et al. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. , 1998 .
[12] G. Duvel. The study group. , 1980 .
[13] Michael M Engelgau,et al. Elevated blood pressure among U.S. adults with diabetes, 1988-1994. , 2002, American journal of preventive medicine.
[14] Standards of Medical Care for Patients With Diabetes Mellitus , 1991, Diabetes Care.
[15] D. Snider,et al. Prevalence of diabetes and impaired fasting glucose in adults--United States, 1999-2000. , 2003, MMWR. Morbidity and mortality weekly report.
[16] Adrienne Jones. The National Nursing Home Survey: 1999 summary. , 2002, Vital and health statistics. Series 13, Data from the National Health Survey.
[17] Matthew D. Davis,et al. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. , 2002, JAMA.
[18] F. Vinicor,et al. The National Diabetes Education Program, Changing the Way Diabetes Is Treated Comprehensive diabetes care , 2001 .
[19] A. Mokdad,et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. , 2003, JAMA.
[20] Jeannine S. Schiller,et al. Summary health statistics for U.S. adults: National Health Interview Survey, 2000. , 2003, Vital and health statistics. Series 10, Data from the National Health Survey.
[21] T. Lennie,et al. Perceived Adherence to Prescribed or Recommended Standards of Care Among Adults With Diabetes , 2002, The Diabetes educator.
[22] James C. Robinson,et al. As good as it gets? Chronic care management in nine leading US physician organisations , 2002, BMJ : British Medical Journal.
[23] C. Johnston,et al. Optimizing treatment of hypertension in patients with diabetes. , 2000, JAMA.
[24] S. Tesfaye. Neuropathy in diabetes , 2006 .
[25] K. Flegal,et al. Prevalence and trends in obesity among US adults, 1999-2000. , 2002, JAMA.
[26] 岩崎 二郎,et al. National Cholesterol Education Program (NCEP) 第2次指針による高脂血症の検討 , 1995 .
[27] E. Steinberg,et al. Improving the quality of care--can we practice what we preach? , 2003, The New England journal of medicine.
[28] Oluf Pedersen,et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. , 2003, The New England journal of medicine.
[29] Y. Li,et al. [Trends in prevalence, awareness, treatment and control of hypertension in middle-aged Chinese population]. , 2004, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.
[30] R. Klein. Hyperglycemie and Microvascular and Macrovascular Disease in Diabetes , 1995, Diabetes Care.
[31] M. Laakso,et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. , 1998, The New England journal of medicine.
[32] S. Haffner. Management of Dyslipidemia in Adults With Diabetes , 1998, Diabetes Care.
[33] L. Egede,et al. Modifiable cardiovascular risk factors in adults with diabetes: prevalence and missed opportunities for physician counseling. , 2002, Archives of internal medicine.
[34] E. Gunter,et al. Laboratory procedures used for the third National Health and Nutrition Examination Survey (NHANES III), 1988-1994 , 1996 .
[35] Ihab Hajjar,et al. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. , 2003, JAMA.
[36] D. O'leary,et al. Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. , 2003, The New England journal of medicine.
[37] M. Engelgau,et al. A Diabetes Report Card for the United States: Quality of Care in the 1990s , 2002, Annals of Internal Medicine.
[38] C. Gabrel,et al. The National Nursing Home Survey: 1999 summary. , 2002, Vital and health statistics. Series 13, Data from the National Health Survey.
[39] W. O’Neill,et al. Treatment of cardiac risk factors in diabetic patients: How well do we follow the guidelines? , 2001, American heart journal.
[40] S. Grundy,et al. Prevention Conference VI: Diabetes and Cardiovascular Disease: Executive Summary Conference Proceeding for Healthcare Professionals From a Special Writing Group of the American Heart Association , 2002, Circulation.
[41] M. Szklo,et al. Epidemiology: Beyond the Basics , 1999 .
[42] Anke Richter,et al. Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes. , 2002, JAMA.
[43] Joël Ménard,et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial , 1998, The Lancet.
[44] S. Greenfield,et al. The Diabetes Quality Improvement Project: moving science into health policy to gain an edge on the diabetes epidemic. , 2001, Diabetes care.
[45] R. Holman,et al. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .
[46] Teven,et al. MORTALITY FROM CORONARY HEART DISEASE IN SUBJECTS WITH TYPE 2 DIABETES AND IN NONDIABETIC SUBJECTS WITH AND WITHOUT PRIOR MYOCARDIAL INFARCTION , 2000 .